Researchers at the University of Rochester Medical Center and University of Nebraska Medical Center have received a $3.4 million grant from the National Institutes of Health to study an experimental drug combination that appears to rid white blood cells of HIV and keep the infection in check for long periods. While current HIV treatments involve pills that are taken daily, the experimental drugs’ long-lasting effects suggest the possibility of an HIV treatment that could be administered monthly, or perhaps a few times a year.
Rochester Business Journal
12 August 2014
The Entrepreneurs Network is soliciting applications for its 17th class, with sessions to begin next month.
The class will meet monthly at High Tech Rochester Inc. in Henrietta and other venues in the Rochester area beginning Sept. 18 and ending in December, officials said.
The class is limited to 15 members. The application deadline is Sept. 5. Upon acceptance, members pay an all-inclusive fee of $350.
Experiment measures millions of quantum trajectories to predict ‘most likely’ route
As a quantum state collapses from a quantum superposition to a classical state or a different superposition, it will follow a path known as a quantum trajectory. For each start and end state there is an optimal or “most likely” path, but it is not as easy to predict the path or track it experimentally as a straight-line between two points would be in our everyday, classical world.